Vasodilator Agents
Research News and Information

Sunday, November 22, 2009

Impairment of intracerebral arteriole dilation responses after subarachnoid hemorrhage. Laboratory investigation.

30 Oct 2009 OBJECT: Cerebrovascular dysfunction after subarachnoid hemorrhage (SAH) may contribute to ischemia, but little is known about the contribution of intracerebral arterioles. In this study, the authors tested the hypothesis that SAH inhibits the ... Read more...

Nonarteritic ischaemic optic neuropathy (NAION) after 36 h of intake of sildenafil citrate: first Egyptian case.

29 Sep 2009 Sildenafil citrate is a selective phosphodiesterase 5 (PDE-5) inhibitor and partial phosphodiesterase 6 inhibitor prescribed for erectile dysfunction. Post-marketing case reports of nonarteritic anterior ischaemic optic neuropathy (NAION) over the ... Read more...

Acute myocardial infarction due to vasospasm induced by prostaglandin.

29 Sep 2009 Prostaglandin E (PGE) is the preferred agent for second-trimester pregnancy termination. Hypotension, bradycardia, ventricular arrhythmias, myocardial infarction, cardiac arrest and death associated with PGE have been reported. A case of acute ... Read more...

Latest indexed articles for 'Vasodilator Agents'

These are the very latest articles for this heading:

• Intracisternal irrigation of papaverine leading to choroidal infarction. 30 Oct 2009
• Impairment of intracerebral arteriole dilation responses after subarachnoid hemorrhage. Laboratory investigation. 30 Oct 2009
• Dopexamine and survival: areas of consistency. 30 Oct 2009
• False-positive stress tests... or false-negative rest angiograms? 25 Oct 2009
• Nonarteritic ischaemic optic neuropathy (NAION) after 36 h of intake of sildenafil citrate: first Egyptian case. 29 Sep 2009
• Iloprost-induced rash. 29 Sep 2009
• Acute myocardial infarction due to vasospasm induced by prostaglandin. 29 Sep 2009
• Structural determination of sildenafil and its analogues in dietary supplements by fast-atom bombardment collision-induced dissociation tandem mass spectrometry. 29 Sep 2009
• Recurrent ventricular fibrillation due to coronary artery spasm immediately after ascending aorta replacement. 29 Sep 2009
• [The effect of autogenic training combined with organ formula and movement therapy on spontaneous and provoked migraine headaches] 28 Sep 2009
• [Risk prediction using cardiovascular magnetic resonance imaging] 21 Sep 2009
• Dietary polyphenols generate nitric oxide from nitrite in the stomach and induce smooth muscle relaxation. 20 Sep 2009
• Regadenoson: a new myocardial stress agent. 20 Sep 2009
• eNOS uncoupling and endothelial dysfunction in aged vessels. 16 Sep 2009
• Association between widowhood and risk of diagnosis with a sexually transmitted infection in older adults. 15 Sep 2009
• Stress computed tomography myocardial perfusion: steps, questions, and layers. 13 Sep 2009
• Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. 13 Sep 2009
• Pulmonary hypertensive medical therapy in chronic thromboembolic pulmonary hypertension before pulmonary thromboendarterectomy. 12 Sep 2009
• Absence of adenosine-mediated aortic relaxation in A(2A) adenosine receptor knockout mice. 9 Sep 2009
• Impaired function of coronary BK(Ca) channels in metabolic syndrome. 9 Sep 2009

See a longer list of these articles.

Technical information about 'Vasodilator Agents'

Definition: Drugs used to cause dilation of the blood vessels.

Registry Number: 0

Descriptor UI: D014665

Alternative terms: Vasodilator Agents; Agents, Vasodilator; Vasodilator Drugs; Drugs, Vasodilator; Vasodilators; Vasoactive Antagonists; Antagonists, Vasoactive;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.411.918;

Technical Notes: consider also VASOMOTOR SYSTEM /drug eff